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Abstract - Glucocorticoid hormones are thought to play a role in the regulation of 
clock genes involved in the generation of circadian rhythms in peripheral tissues 
(Balsalobre et al., 2000a, Balsalobre et al., 2000b).  Little is known about the role 
of glucocorticoids in the control of clock genes in the brain although there is 
evidence that clock genes in the suprachiasmatic nucleus (SCN), the master 
circadian pacemaker in mammalian brain, are invulnerable to glucocorticoids 
(Balsalobre et al., 2000a).  We investigated the involvement of the adrenal 
glucocorticoid, corticosterone, in the control of the clock protein, PER2, in 
forebrain nuclei known to be sensitive to glucocorticoids, stressors and drugs of 
abuse, the oval nucleus of the bed nucleus of the stria terminalis (BNSTov) and 
the central nucleus of the amygdala (CEA) (Schulkin et al., 1998, Day et al., 
1999, Day et al., 2001, Erb et al., 2001, Engstrom et al., 2003).  We found earlier 
that the daily rhythm of PER2 in these nuclei is uniquely dependent on the 
integrity of the adrenal glands (Amir et al., 2004, Lamont et al., 2005).  We now 
show that in the absence of the adrenals, a treatment that establishes a daily 
rhythm of corticosterone, but not one that provides constant corticosterone 
levels, restores the rhythm of PER2 in the BNSTov and CEA.  These results 
underscore the importance of circadian glucocorticoid signaling in PER2 rhythms 
in the BNSTov and CEA and suggest a novel mechanism whereby stressors, 
drugs of abuse, and other abnormal states that affect the patterns of circulating 
glucocorticoids can alter the functional output of these nuclei. 
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We have shown that the PER2 protein is expressed rhythmically in several key 
structures of the rat limbic forebrain.  These include two anatomically and 
functionally related nuclei of the central extended amygdala, the BNSTov and 
CEA, and two functionally related cortical-like structures, the basolateral 
amygdala (BLA) and dentate gyrus (DG) (Amir et al., 2004, Lamont et al., 2005).  
Furthermore, we found that although the rhythms of expression of PER2 in these 
structures are all under the control of the SCN, the rhythms in the BNSTov and 
CEA and those in the BLA and DG are diametrically opposite in phase, with 
those in the BNSTov and CEA peaking in the evening, in phase with the SCN 
rhythm, and those in the BLA and DG peaking in the morning.  Most importantly, 
the PER2 rhythms in the BNSTov and CEA and those in the BLA and DG were 
found to be differentially affected by adrenalectomy (Amir et al., 2004, Lamont et 
al., 2005).  Adrenalectomy abolished the PER2 rhythms in the BNSTov and CEA, 
but had no effect on the those in BLA and DG, suggesting that glucocorticoids 
play a selective role in the regulation of the rhythms in BNSTov and CEA.  To 
study further this issue, we assessed the effect of corticosterone replacement via 
the drinking water (a manipulation that reinstates the daily rhythm of 
corticosterone) or via time-release pellets (to induce constant levels of 
corticosterone) on the daily pattern of expression of PER2 immunoreactivity in 
the BNSTov and CEA, as well as in the SCN, BLA and DG in sham operated and 




Animals and Housing 
All experimental procedures were approved by the Animal Care Committee of 
Concordia University in accordance with the guidelines set by the Canadian 
Council on Animal Care.  Bilaterally adrenalectomized (n=64) and intact (n=32) 
male Wistar rats weighing 225-250g were purchased from Charles River Canada 
(St. Constant, Quebec).  They were housed individually in clear plastic shoebox 
cages, under a 12h:12h light/dark (LD) schedule, and were provided with ad 
libitum access to food and either 0.9% saline or saline containing corticosterone 
(Sigma, 25 mg/L). 
 
Sham adrenalectomy 
Thirty-two rats underwent sham adrenalectomy under Isoflurane anesthesia in 
which bilateral incisions were made in the skin and immediately closed with 
stainless steel wound clips. 
  
Pellet implantation 
Thirty-two bilaterally adrenalectomized rats were anesthetized with isofluorane 
and a small incision was made in the skin of the scruff region.  A pocket was 
made by separating the skin from the muscle tissue and a 100 mg 30-day slow 
release pellet was implanted. Sixteen rats received corticosterone pellets 
(Innovative Research of America (Sarasota, Florida), while the remaining 16 rats 
received cholesterol control pellets. The skin wounds were closed with stainless 
steel wound clips. 
 
Plasma collection and corticosterone determination 
Rats were placed in plastic restraining devices and tail-clipped for rapid blood 
collection (1.5 ml).  Sample were centrifuged at 4 °C, 13,000 rpm for ten min, and 
the plasma was extracted and stored at –80 °C.  Plasma corticosterone levels 
were assessed in duplicates using radioimmunoassay (RIA).  
 
Tissue preparation and immunocytochemistry 
Rats were injected with an overdose of sodium pentobarbital (~100 mg/kg) at one 
of four zeitgeber times (ZT1, ZT7, ZT13, ZT19; ZT0 denotes time of light on) and 
were perfused intracardially with 300 ml of cold saline (0.9% NaCl) followed by 
300 ml of cold, 4% paraformaldehyde in a 0.1 M phosphate buffer (pH 7.3).  
Following perfusion, brains were postfixed in 4% paraformaldehyde and stored at 
4° C overnight.  Serial coronal brain sections (50 µm) containing regions of 
interest were collected from each animal using a vibratome and stored in 
Watson’s Cryoprotectant solution at -20 °C.  Immunocytochemistry for PER2 was 
performed as previously described (Amir et al., 2004) using an affinity purified 
rabbit polyclonal antibody raised against PER2 (1:800, ADI, San Antonio, TX).  
Stained  sections were mounted onto gel-coated slides dehydrated in a series of 
alcohols and Citrisolv (Fisher), and cover-slipped. 
 
Data Analysis 
PER2-stained brain sections were examined under a light microscope and 
images were captured using a Sony XC-77 video camera, a Scion LG-3 frame 
grabber, and Image SXM software (v1.6, S. D. Barrett, 
http://www.ImageSXM.org.uk).  Cells immunopositive for PER2 were counted 
manually using a 400 X 400 µm template (SCN, BNSTov, CEA, BLA) or 200 X 
400 µm template (DG). For analysis, the mean number of PER2 immunoreactive 
cells per region was calculated for each animal from the counts of 6 unilateral 
images showing the highest number of labeled nuclei.  Differences between 
groups were revealed with analysis of variance (ANOVA).  Alpha level was set at 
0.05 for all analyses 
 
RESULTS AND DISCUSSION 
 
As expected, in sham operated rats that were given saline as the drinking fluid 
(four weeks), PER2 expression in SCN, BNSTov and CEA peaked at ZT13, 
whereas in BLA and DG, PER2 peaked at ZT1 as shown by the 
photomicrographs in Fig. 1a and the data in Fig. 1b.  Furthermore, corticosterone 
administration in the drinking water (four weeks) had no effect on PER2 rhythms 
in sham operated rats in any of the regions studied. 
 
 Fig. 2a shows the daily pattern of PER2 expression within all areas in 
bilaterally adrenalectomized rats that received saline or corticosterone in the 
drinking fluid (four weeks).  As expected, in adrenalectomized rats given saline, 
the rhythm of PER2 in BNSTov and CEA was abolished (BNSTov, F[3,9]=.83, 
p=.5); CEA, F[3,9]=.4, p=.75), whereas in SCN, BLA and DG adrenalectomy had 
no effect (SCN,F[3,9]=25.24, p<.0001; BLA, F[3,9]=10.37, p=.001; DG, 
F[3,9]=35.22, p<0001).  In contrast, in adrenalectomized rats given 
corticosterone, the rhythm of PER2 expression in BNSTov and CEA was 
completely restored (BNSTov, F[3,9]=29.63, p<.0001; CEA, F[3,9]=8.73, p=.005).  
Results of corticosterone RIA performed on plasma taken from adrenalectomized 
rats receiving corticosterone in the drinking fluid showed that rats self-
administered the hormone mainly during the night (in µg/dL: ZT1=6.1±2.0; 
ZT7=2.8±1.3; ZT13=11.05±2.6; ZT19=6.7±2.2; F[3,10]=2.97, p=.08).  
Adrenalectomized rats receiving saline as the drinking fluid exhibited negligible 
levels of circulating corticosterone (in µg/dL: ZT1=0.14±.04; 
ZT7=.60±.30;ZT13=2.1±.74; ZT19=.95±.43; F[3,10]=.83, p=.50). 
 
Although these findings demonstrate that corticosterone can restore the 
rhythmic expression of PER2 in BNSTov and CEA of adrenalectomized rats, they 
do not tell us whether it is the rhythm of corticosterone that is critical or whether 
the mere presence of corticosterone is sufficient.  To address this issue, we 
assessed the expression of PER2 in two additional bilaterally adrenalectomized 
groups that were implanted subcutaneously with time-release pellets containing 
corticosterone or cholesterol. 
 
It is apparent from the data shown in Fig. 2b that corticosterone 
replacement by time-release pellets  (30-day, 100 mg) did not restore rhythmic 
PER2 expression in either BNSTov or CEA. The ANOVAs revealed no effect of 
either Treatment (BNSTov, F[1,12]=.06, p=.80; CEA,F[1,12]=.18, p=.67) or 
Treatment x Time interactions (BNSTov, F[3,12]=1.68, p=.22; CEA,F[3,12]=1.13, 
p=.37).  Note that PER2 expression in all other regions was rhythmic and 
unaffected by pellet replacement.  Results of the RIA showed that 
adrenalectomized rats receiving corticosterone via time-release pellets had 
constantly high levels of plasma corticosterone (in µg/dL: ZT1=13.34±.95; 
ZT7=14.7±1.07; ZT13=11.62±3.29; ZT19=11.92±2.13; F[3,12]=.46, p=.71).  
Adrenalectomized rats treated with cholesterol pellets exhibited negligible levels 
of circulating corticosterone (in µg/dL: ZT1=1.7±.93; ZT7=2.12±.98; 
ZT13=.80±.27; ZT19=1.25±.38; F[3,7]=.32, p=.80). 
 
Taken together the results of these experiment show that following 
adrenalectomy the rhythms of expression of the clock protein, PER2, in the 
BNSTov and CEA can be restored by a daily rhythm in corticosterone level, but 
not by a constant level of corticosterone achieved by time-release pellets.  These 
findings suggest that the rhythm of expression of PER2 in these nuclei is 
controlled by the daily fluctuation of corticosterone secretion from the adrenal 
gland.  It is important to note that the rhythm of corticosterone induced by 
drinking in adrenalectomized rats and that seen under basal conditions in intact 
rats follow similar circadian patterns, both of which are under the control of the 
SCN (Moore and Eichler, 1972, Szafarczyk et al., 1983, Satinoff and Prosser, 
1988, Engeland and Arnhold, 2005).  Thus, corticosterone could serve as 
mediator between the SCN and the rhythmic expression of clock genes not only 
in peripheral tissues, as previously proposed (Balsalobre et al., 2000a 
Balsalobre, 2000 #12, Bittman et al., 2003, Yamamoto et al., 2005), but also in 
select brain nuclei such as the BNSTov and CEA.   
 
The mechanism by which corticosterone controls PER2 rhythms in the 
BNSTov and CEA is unknown.  Both the BNSTov and CEA are sensitive to 
glucocorticoids (Honkaniemi et al., 1992, Makino et al., 1994b, Makino et al., 
1994a, Pompei et al., 1995, Watts and Sanchez-Watts, 1995, Schulkin et al., 
1998, Lechner and Valentino, 1999), but they are not unique in that respect.  
Indeed, as is the case with BNSTov and CEA, the hippocampus and BLA contain 
glucocorticoid receptors, activation of which affect diverse physiological and 
behavioral processes (Jacobson and Sapolsky, 1991, Ahima et al., 1992, 
Morimoto et al., 1996, Roozendaal and McGaugh, 1997, Sousa and Almeida, 
2002, Conrad et al., 2004). Unlike the BNSTov and CEA, however, the rhythmic 
expression of PER2 in these regions is unaffected by adrenalectomy or by 
rhythmic or constant levels of replacement of corticosterone.  Cells within the 
BNSTov and CEA express a variety of neuropeptides, including corticotropin-
releasing hormone (CRH) and enkephalin (ENK) (Honkaniemi et al., 1992, 
Schulkin et al., 1998, Dong et al., 2001, Kozicz and Arimura, 2001, Kozicz, 
2002).  We have reported previously that in both nuclei, PER2 is expressed in 
ENK neurons (Amir et al., 2004, Lamont et al., 2005).  Thus, it is possible that the 
changes in the rhythm of PER2 expression observed after adrenalectomy and 
corticosterone replacement are due to a direct effect of glucocorticoids on these 
neurons.  Although PER2 appears not to be expressed in CRH containing 
neurons, we cannot rule out an indirect effect of glucocorticoids on the rhythm of 
PER2 expression via their well known effects on these CRH neurons.   
 
 The finding that the BNSTov and the CEA exhibit daily rhythms in PER2 
that depend on rhythmic glucocorticoid signaling suggest that abnormalities in 
the daily rhythms of circulating glucocorticoids induced by events such as chronic 
exposure to stressors or to drugs of abuse, as well abnormalities induced by 
disease states, such as Cushing’s disease, could directly affect the local 
expression of circadian clock genes.  Because the BNSTov and CEA have 
important roles in the control of emotional and motivational states, such 
persistent disruptions of local circadian functioning could lead to the development 
of abnormal autonomic, endocrine and behavioral responses to motivationally 
and emotionally significant stimuli.  
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a, Examples of PER2 expression in the SCN, BNSTov, CEA, BLA and DG at ZT1 
and ZT13 in sham-operated rats given 0.9% saline (four weeks) as the drinking 
fluid (magnification: x20); b, Number of PER2 – immunoreactive cells in the SCN, 
BNSTov, CEA, BLA and DG as a function of zeitgeber time (ZT) in sham-
operated rats given 0.9% saline or saline containing corticosterone (CORT, 25 




a, Number of PER2 – immunoreactive cells in the SCN, BNSTov, CEA, BLA and 
DG as a function of zeitgeber time (ZT) in groups of adrenalectomized rats given 
0.9% saline or saline containing corticosterone (CORT, 25 mg/L) as the drinking 
fluid (four weeks) (Means + S.E. are shown, n=3-4 per point); b, Number of 
PER2 – immunoreactive cells in the SCN, BNSTov, CEA, BLA and DG as a 
function of zeitgeber time (ZT) in groups of adrenalectomized rats given 0.9% 
saline as the drinking fluid and a subcutaneous time-release pellet (100 mg, 30-
day) containing cholesterol (Chol) or corticosterone (CORT) (Means + S.E. are 
shown, n=3-4 per point).  
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